| Application no. and date | 10170408.8 (espacenet) (Federated) (European Patent Register), 20011016 | | Patent/reg. no. and date | DK/EP 2266603, 20120912 | | Publication date | 20101229 | | Priority no. and date | GB 0025573, 20001018, US 690921, 20001018, GB 0025574, 20001018 | | EP pub. no. and date |
EP 2266603 20101229 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals S.A., Rue de l'Institut, 89
1330 Rixensart, BE | | Applicant ref. no. | 156957 | | Inventor | Garcon, Nathalie, GlaxoSmithKline Biologicals s.a.
rue de l'Institut 89
B-1330, Rixensart, BE,
Gerard, Catherine Marie Ghislaine, GlaxoSmithKline Biologicals s.a.
rue de l'Institut 89
B-1330, Rixensart, BE,
Stephenne, Jean, GlaxoSmithKline Biologicals s.a.
rue de l'Institut 89
B-1330, Rixensart, BE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/39 (2006.01) , A61P 35/00 (2006.01) | | Title | Tumorvacciner | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
